Funder: National Ataxia Foundation
Due Dates (Anticipated): August 2026 (Letter of Intent) | December 2026 (Full application)
Funding Amounts: Up to $100,000 for one year; direct research expenses only; no indirect costs allowed.
Summary: Funds innovative translational, preclinical, or clinical research to accelerate therapies, biomarkers, and care for Spinocerebellar Ataxia Type 3.
Key Information: Applicants may only submit one application per year and must not have been lead PI on a funded NAF grant in the past two years.